Last reviewed · How we verify

Dexpanthenol (BAY81-2996) — Competitive Intelligence Brief

Dexpanthenol (BAY81-2996) (Dexpanthenol (BAY81-2996)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B5 analog / Tissue repair agent. Area: Dermatology / Wound Care.

marketed Vitamin B5 analog / Tissue repair agent Pantothenic acid pathway / Coenzyme A synthesis Dermatology / Wound Care Small molecule Live · refreshed every 30 min

Target snapshot

Dexpanthenol (BAY81-2996) (Dexpanthenol (BAY81-2996)) — Bayer. Dexpanthenol is converted to pantothenic acid (vitamin B5), which serves as a precursor for coenzyme A, essential for cellular metabolism and tissue repair.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dexpanthenol (BAY81-2996) TARGET Dexpanthenol (BAY81-2996) Bayer marketed Vitamin B5 analog / Tissue repair agent Pantothenic acid pathway / Coenzyme A synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B5 analog / Tissue repair agent class)

  1. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dexpanthenol (BAY81-2996) — Competitive Intelligence Brief. https://druglandscape.com/ci/dexpanthenol-bay81-2996. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: